Pinkett v. Dr. Leonard's Healthcare Corp.

CourtDistrict Court, District of Columbia
DecidedApril 27, 2021
DocketCivil Action No. 2018-1656
StatusPublished

This text of Pinkett v. Dr. Leonard's Healthcare Corp. (Pinkett v. Dr. Leonard's Healthcare Corp.) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pinkett v. Dr. Leonard's Healthcare Corp., (D.D.C. 2021).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

RENE PINKETT,

Plaintiff, v. Civil Action No. 18-1656 (JEB) DR. LEONARD’S HEALTHCARE CORP.,

Defendant.

MEMORANDUM OPINION

After sustaining injuries from a B Yours Vibe 2 vibrator, Plaintiff Rene Pinkett sued both

the product’s seller and its manufacturer, asserting a number of tort claims. After several rounds

of dispositive motions, all that remains is one Defendant and one count. See Pinkett v. Dr.

Leonard's Healthcare Corp., 2020 WL 1536305, at *1 (D.D.C. Mar. 31, 2020). Her surviving

claim seeks to hold the seller — Dr. Leonard’s Healthcare Corp. — liable for an alleged design

defect in the vibrator. Pinkett is suing for non-economic damages only, and, with trial

approaching, she now moves to bar the defense from introducing evidence of the amount of

medical expenses she incurred in relation to this incident. Defendant rejoins that the medical

bills should be admissible because they are relevant to proving whether or not Plaintiff was truly

injured. The Court will grant the Motion to exclude evidence as to the cost of her treatments, but

Dr. Leonard’s remains free to introduce any otherwise admissible evidence regarding their scope,

nature, and frequency.

1 I. Legal Standard

“[M]otions in limine are a means for arguing why ‘evidence should or should not, for

evidentiary reasons, be introduced at trial.’” Graves v. Dist. of Columbia., 850 F. Supp. 2d 6, 11

(D.D.C. 2011) (emphasis omitted) (quoting Williams v. Johnson, 747 F. Supp. 2d 10, 18 (D.D.C.

2010)). They “are ‘designed to narrow the evidentiary issues for trial and to eliminate

unnecessary trial interruptions.’” Id. at 10 (quoting Bradley v. Pittsburgh Bd. of Educ., 913 F.2d

1064, 1069 (3d Cir. 1990)). The court has “broad discretion in rendering evidentiary rulings, . . .

which extends . . . to the threshold question of whether a motion in limine presents an evidentiary

issue that is appropriate for ruling in advance of trial.” Barnes v. Dist. of Columbia, 924 F.

Supp. 2d 74, 79 (D.D.C. 2013).

II. Analysis

Pinkett argues that any evidence of the cost of her medical treatments is irrelevant to the

severity of her injuries and should thus be excluded. Under Federal Rule of Evidence 401,

evidence is relevant if “(a) it has any tendency to make a fact more or less probable than it would

be without the evidence; and (b) the fact is of consequence in determining the action.” The

“general rule” is that relevant evidence is admissible, unless otherwise prohibited. United States

v. Foster, 986 F.2d 541, 545 (D.C. Cir. 1993) (paraphrasing Fed. R. Evid. 402). The defense

argues that “[t]he scope of Plaintiff’s alleged medical treatment in connection with the subject

occurrence, including the medical expenses associated therewith, certainly has the tendency to

make Plaintiff’s allegations that she was injured, and therefore experienced pain and suffering,

more or less probable than it would be without the evidence.” ECF No. 44 (Def. Opp.) at 2

(citation and internal quotations omitted). Dr. Leonard’s is correct that the scope of Plaintiff’s

medical treatment is certainly relevant, but federal courts have generally found that “[t]he price

2 tag of treatment does not tend to prove or disprove anything about the nature and extent of

injuries, save what it has cost to treat them.” Francis v. Nat’l R.R. Passenger Corp., 661 F. Supp.

244, 245 (D. Md. 1987). For that reason, where plaintiff cannot or does not seek to “recover that

cost, . . . the evidence of cost is irrelevant.” Id.; see also Varhol v. Nat’l R.R. Passenger Corp.,

909 F.2d 1557, 1566 (7th Cir. 1990) (“[S]ince [plaintiff] could not recover the expenses reflected

in those bills, the amounts of those expenses bore little, if any, relevance to this case.”).

The most widely traveled federal authority on this issue is Payne v. Wyeth

Pharmaceuticals, Inc., No. 08-119, 2008 WL 4890760 (E.D. Va. Nov. 12, 2008), which found

that “there is no logical or experiential correlation between the monetary value of medical

services required to treat a given injury and the quantum of pain and suffering endured as a result

of that injury.” Id. at *6 (quoting and adopting reasoning of Carlson v. Bubash, 639 A.2d 458,

462 (Pa. Super. Ct. 1994)). Payne reasoned, inter alia, that the cost of treatment may mask the

differences in severity between different types of injuries, and that expenses may vary depending

on the facility and physician. Id. While Payne was a case where the defendant sought to exclude

medical bills, its holding and rationale have been applied to cases like this one where the plaintiff

is the one seeking exclusion. See Campbell v. Garcia, No. 13-627, 2016 WL 4769728, at *7 (D.

Nev. Sept. 13, 2016) (granting plaintiff’s motion to exclude because “there is no relevance

between these costs and [plaintiff’s] purported pain and suffering”).

Even if the Court found that Pinkett’s medical bills had some slight relevance, they

would still be inadmissible under Federal Rule of Evidence 403, which provides that “[t]he court

may exclude relevant evidence if its probative value is substantially outweighed by a danger of

. . . unfair prejudice, confusing the issues, misleading the jury, . . . or needlessly presenting

cumulative evidence.” Here, as in Payne, “there is a substantial possibility of jury confusion if

3 the medical bills were introduced to prove pain and suffering” or, in this case, lack thereof,

where Pinkett does not seek to recover for any outlay. Id. at *7; see also Varhol, 909 F.2d at

1566 (“Even if the amounts were somehow relevant, the district court did not abuse its discretion

in finding the possibility of jury confusion, misuse, and double-recovery outweighed the bills’

probative value.”).

The Court does not dispute Defendant’s position that “[t]he scope of Plaintiff’s alleged

medical treatment in connection with the subject occurrence” is relevant in determining

Plaintiff’s true pain and suffering. See Def. Opp. at 2 (emphasis added). But nothing in this

Order prevents it from detailing this; the only evidence precluded is how much she happened to

pay for that treatment. Defendant may still introduce otherwise admissible evidence as to the

number of medical appointments Pinkett attended, any diagnoses, and the types and

extensiveness of the treatments provided.

III. Conclusion

For the reasons stated above, the Court will grant Plaintiff’s Motion to exclude evidence

as to the amount of past medical expenses incurred here. A separate Order so stating will issue

this day.

/s/ James E. Boasberg JAMES E. BOASBERG United States District Judge Date: April 27, 2021

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. James Anthony Foster
986 F.2d 541 (D.C. Circuit, 1993)
Carlson v. Bubash
639 A.2d 458 (Superior Court of Pennsylvania, 1994)
Francis v. NATIONAL RR PASSENGER CORP.(AMTRAK)
661 F. Supp. 244 (D. Maryland, 1987)
Williams v. Johnson
747 F. Supp. 2d 10 (District of Columbia, 2010)
Barnes v. District of Columbia
924 F. Supp. 2d 74 (District of Columbia, 2013)
Graves v. District of Columbia
850 F. Supp. 2d 6 (District of Columbia, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Pinkett v. Dr. Leonard's Healthcare Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/pinkett-v-dr-leonards-healthcare-corp-dcd-2021.